Reliability of EGFR and KRAS mutation analysis on fine-needle aspiration washing in non-small cell lung cancer

Lung Cancer

Volumn 80, Issue 1, 2013, Pages 35-38

  Bozzetti, Cecilia ^a   Naldi, Nadia ^a   Nizzoli, Rita ^a   Azzoni, Cinzia ^a   Bortesi, Beatrice ^a   Zobbi, Valentina ^a   Bottarelli, Lorena ^a   Tiseo, Marcello ^a   Gasparro, Donatello ^a   Majori, Maria ^a   De Filippo, Massimo ^a   Ardizzoni, Andrea ^a  

^a UNIVERSITY HOSPITAL OF PARMA   (Italy)

Author keywords

Cytology; EGFR mutation; Fine needle aspiration; KRAS mutation; Mutation analysis; Non small cell lung cancer

Indexed keywords

DNA; K RAS PROTEIN; SODIUM CHLORIDE; VASCULOTROPIN RECEPTOR;

ARTICLE; ASPIRATION CYTOLOGY; CLINICAL ARTICLE; CLINICAL EVALUATION; CONTROLLED STUDY; DIAGNOSTIC PROCEDURE; FINE NEEDLE ASPIRATION BIOPSY; GENE DUPLICATION; GENE MUTATION; GIEMSA STAIN; HUMAN; HUMAN CELL; HUMAN TISSUE; LUNG NON SMALL CELL CANCER; MEDICAL DECISION MAKING; METASTASIS; MOLECULAR DIAGNOSTICS; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; RELIABILITY; SAMPLING;

AMINO ACID SUBSTITUTION; BIOPSY, FINE-NEEDLE; CARCINOMA, NON-SMALL-CELL LUNG; DNA MUTATIONAL ANALYSIS; HUMANS; LUNG; LUNG NEOPLASMS; MUTATION; POLYMERASE CHAIN REACTION; PROTO-ONCOGENE PROTEINS; RAS PROTEINS; RECEPTOR, EPIDERMAL GROWTH FACTOR; REPRODUCIBILITY OF RESULTS; SENSITIVITY AND SPECIFICITY; SEQUENCE DELETION;

EID: 84875241204     PISSN: 01695002     EISSN: 18728332     Source Type: Journal    
DOI: 10.1016/j.lungcan.2013.01.007     Document Type: Article

References (15)

1. Malapelle U., Bellevicine C., Zeppa P., Palombini L., Troncone G. Cytology-based gene mutation tests to predict response to anti-epidermal growth factor receptor therapy: a review. Diagn Cytopathol 2011, 39:703-710.
2. Moreira A.L., Thornton R.H. Personalized medicine for non-small-cell lung cancer: implications of recent advances in tissue acquisition for molecular and histologic testing. Clin Lung Cancer 2012, (March). doi: 10.1016/j.cllc.2012.01.004.
3. Rossi G., Pelosi G., Graziano P., Barbareschi M., Papotti M. A reevaluation of the clinical significance of histological subtyping of non-small-cell lung carcinoma: diagnostic algorithms in the era of personalized treatments. Int J Surg Pathol 2009, 17:206-218.
4. Cheng L., Zhang S., Alexander R., Yao Y., MacLennan G.T., Pan C.X., et al. The landscape of EGFR pathways and personalized management of non-small-cell lung cancer. Future Oncol 2011, 7:519-541.
5. Nizzoli R., Tiseo M., Gelsomino F., Bartolotti M., Majori M., Ferrari L., et al. Accuracy of fine needle aspiration cytology in the pathological typing of non-small cell lung cancer (NSCLC). J Thorac Oncol 2011, 6:489-493.
6. Bozzetti C., Negri F.V., Azzoni C., Naldi N., Nizzoli R., Bortesi B., et al. Epidermal growth factor receptor (EGFR) and KRAS gene expression: reliability of mutational analysis on cytological samples. Diagn Cytopathol 2012, (July). doi: 10.1002/dc.22905.
7. Lynch T.J., Bell D.W., Sordella R., Gurubhagavatula S., Okimoto R.A., Brannigan B.W., et al. Activating mutations in epidermal growth factor receptor underlying responsiveness of non-small-cell lung cancer to gefitinib. N Engl J Med 2004, 350:2129-2139.
8. Paez J.G., Jänne P.A., Lee J.C., Tracy S., Greulich H., Gabriel S., et al. EGFR mutations in lung cancer: correlation with clinical response to gefitinib therapy. Science 2004, 304:1497-1500.
9. Otani H., Toyooka S., Soh J., Yamamoto H., Suehisa H., Kobayashi N., et al. Detection of EGFR gene mutations using the wash fluid of CT-guided biopsy needle in NSCLC patients. J Thorac Oncol 2008, 3:472-476.
10. Horiike A., Kimura H., Nishio K., Ohyanagi F., Satoh Y., Okumura S., et al. Detection of epidermal growth factor receptor mutation in transbronchial needle aspirates of non-small cell lung cancer. Chest 2007, 131:1628-1634.
11. Malapelle U., de Rosa N., Bellevicine C., Rocco D., Vitiello F., Piantedosi F.V., et al. EGFR mutations detection on liquid-based cytology: is microscopy still necessary?. J Clin Pathol 2012, 65:561-564.
12. Billah S., Stewart J., Staerkel G., Chen S., Gong Y., Guo M. EGFR and KRAS mutations in lung carcinoma: molecular testing by using cytology specimens. Cancer Cytopathol 2011, 119:111-117.
13. Boldrini L., Gisfredi S., Ursino S., Camacci T., Baldini E., Melfi F., et al. Mutational analysis in cytological specimens of advanced lung adenocarcinoma: a sensitive method for molecular diagnosis. J Thorac Oncol 2007, 2:1086-1090.
14. Rekhtman N., Brandt S.M., Sigel C.S., Friedlander M.A., Riely G.J., Travis W.D., et al. Suitability of thoracic cytology for new therapeutic paradigms in non-small cell lung carcinoma: high accuracy of tumor subtyping and feasibility of EGFR and K-RAS molecular testing. J Thorac Oncol 2011, 6:451-458.
15. Schuurbiers O.C., Looijen-Salamon M.G., Ligtenberg M.J., van der Heijden H.F. A brief retrospective report on the feasibility of epidermal growth factor receptor and KRAS mutation analysis in transesophageal ultrasound- and endobronchial ultrasound-guided fine needle cytological aspirates. J Thorac Oncol 2010, 5:1664-1667.